Stock Market News & Investment Strategy Research

Market Recap

{{Title}} Remove

Stocks Boosted by U.S.-China Trade Momentum

The "phase one" trade deal between the U.S. and China will be signed on Wednesday

January 13, 2020 4:31 PM

Earnings Preview
Intraday Option Activity

{{Title}} Remove

Options Bulls Flock to DAL Stock Ahead of Earnings

Delta Air Line's quarterly report is due out before the open tomorrow

January 13, 2020 2:59 PM

Intraday Option Activity

{{Title}} Remove

Options Volume Ramps Up as DDD, CDLX Stocks Surge

CDLX and DDD stocks are two big winners today on Wall Street

CDLX
DDD

January 13, 2020 1:51 PM

Technical Analysis
Expectational Analysis

{{Title}} Remove

This Jewelry Stock Could Shine Next Month

A short squeeze could power additional gains

January 13, 2020 12:21 PM

Midday Market Check

{{Title}} Remove

Stocks Remain Higher on Trade Deal Optimism

The "phase one" trade deal will reportedly be inked later this week

January 13, 2020 11:35 AM

Analyst Update

{{Title}} Remove

IBM Stock Downgraded as 200-Day Looms

The $138 region in general could be problematic

January 13, 2020 10:10 AM

Buzz Stocks

{{Title}} Remove

Puts Pop as EXAS Heads For Worst Day in 16 Months

EXAS was overbought heading into today, too

EXAS

January 13, 2020 10:05 AM

Buzz Stocks

{{Title}} Remove

LULU Stock Keeps Climbing on Q4 Forecast

Lululemon lifted its fourth-quarter sales and profit forecast

LULU

January 13, 2020 9:32 AM

Opening View

{{Title}} Remove

Stock Futures Climb as Trade Deal Signing Approaches

Bulls are gearing up for the U.S.-China trade deal signing this week

January 13, 2020 9:07 AM

Market Recap

{{Title}} Remove

Stocks Pivot Lower, Nab Weekly Wins

All three benchmarks nabbed big weekly wins

January 10, 2020 4:32 PM

Intraday Option Activity

{{Title}} Remove

Portola Pharmaceuticals Slump Ignites Heavy Call Trading

The company warned of weaker-than-expected Andexxa revenue

PTLA

January 10, 2020 3:19 PM

Intraday Option Activity

{{Title}} Remove

Nektar Therapeutics Options Pop as Stock Soars

Nektar and Bristol-Myers Squibb will expand an ongoing late-stage collaborative trial

January 10, 2020 1:34 PM

A Schaeffer's exclusive

TOP STOCK PICKS 2020

Access your FREE insider report before it's too late!

Browse By Topic

View All Articles By Date

Partnercenter

^NEW!Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers. Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.